SCHEMBL3645476

SCHEMBL3645476

CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCC(C)C)OP(=O)(O)OCCN

nearest known ligand 0.65

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.57
P2RY10 O00398 5/20 0.55
GPR174 Q9BXC1 2/20 0.55
RECQL P46063 1/20 0.53
BLM P54132 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
LPAR3 Q9UBY5 1/20 0.53
GPR34 Q9UPC5 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL190727 0.94 ENPP2 (0.64) ENPP2P2RY10RECQLBLMTDP1
SCHEMBL16714278 0.94 ENPP2 (0.64) ENPP2P2RY10RECQLBLMTDP1
SCHEMBL2126025 0.89 PRKCE (0.61) ENPP2P2RY10RECQLBLMTDP1
SCHEMBL15526366 0.87 ENPP2 (0.59) ENPP2LPAR3
SCHEMBL1402383 0.87 ENPP2 (0.59) ENPP2LPAR3
SCHEMBL8017848 0.83 ENPP2 (0.60) ENPP2RECQLBLMTDP1LPAR3
SCHEMBL23256429 0.83 SELP (0.71) ENPP2P2RY10LPAR3GPR34
SCHEMBL23209666 0.83 SELP (0.71) ENPP2P2RY10LPAR3GPR34
SCHEMBL21641558 0.83 SELP (0.71) ENPP2P2RY10LPAR3GPR34
SCHEMBL23387627 0.83 SELP (0.71) ENPP2P2RY10LPAR3GPR34

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2182923-A1 VIROSOMES COMPRISING HEMAGGLUTININ DERIVED FROM AN INFLUENZA VIRUS PRODUCED IN A CELL LINE, COMPOSITIONS, METHODS OF MANUFACTURING, USE THEREOF Pevion Biotech AG (CH) 2010-05-12 EP disclosed
WO-2009000433-A1 VIROSOMES COMPRISING HEMAGGLUTININ DERIVED FROM AN INFLUENZA VIRUS PRODUCED IN A CELL LINE, COMPOSITIONS, METHODS OF MANUFACTURING, USE THEREOF PEVION BIOTECH AG (CH) 2008-12-31 WO disclosed